scorecardresearchSun Pharmaceutical Industries Share Price Live NSE, BSE, Today - Sun Pharmaceutical

Sun Pharmaceutical Industries

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | SECTOR: Biotechnology & Drugs

1,515.00 5.10 (0.34%)

14 Jun 2024, 09:59 (IST)
  • Open

    1,510.35
  • High

    1,518.30
  • Low

    1,503.90
  • Prev Close

    1,509.90
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    3,634.99B
  • Volume

    49.02K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Promoter Pledge Holding - 1.12%

Promoter NameNo of SharesPercentage
Kumud Shantilal Shanghvi1,00,0000.00%
Raksha S.Valia2,66,90,0001.11%
Aditya Medisales Limited10,0000.00%

Company Description

  • Biotechnology & Drugs
  • BSE

    524715
  • NSE

    SUNPHARMA
  • ISIN

    INE044A01036

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio.

Company Officers

  • C. S. Muralidharan

    Chief Financial Officer
  • Uday Baldota

    Chief Executive Officer - Taro Pharmaceutical Industries Limited
  • S. Damodharan

    Chief Executive Officer - API Business
  • Abhay Gandhi

    Chief Executive Officer - North America
  • Kirti Ganorkar

    Chief Executive Officer - India Business
  • Suresh Rai

    Chief Human Resource Officer, Senior Vice President
  • Dheeraj Sinha

    Executive Vice President, Chief Information Officer
  • Aalok Shanghvi

    Whole-time Director, Executive Vice-President, Emerging Markets, Global generic R&D, Global BD (Generics Segment) & API
  • Jila Breeze

    Executive Vice President, Global Head - Quality
  • Azadar Khan

    Senior Vice-President, Corporate Relations and Corporate Social Responsibility